Dr. Jack Snyder, RAC, DABT, CPI, CPE CATO Research Washington “Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs)” and “FDA Notification and Medical Device Reporting for Laboratory Developed Tests (LDTs)” (issued Oct. 3, 2014) On October 3, 2014, FDA … Continue reading
The post Framework for Regulatory Oversight of Laboratory Developed Tests (LDTs) appeared first on Ask Cato.
